Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)
Conditions
- Diabetes Mellitus, Type 2
- Hypertension
Interventions
- DRUG: Placebo to Ertuglilflozin 1 or 5 mg
- DRUG: Ertugliflozin 1 mg
- DRUG: Ertugliflozin 5 mg
- DRUG: Ertugliflozin 25 mg
- DRUG: HCTZ 12.5mg
- DRUG: Placebo to HCTZ
- DRUG: Placebo to ertuglilflozin 25 mg
Sponsor
Merck Sharp & Dohme LLC
Collaborators